Episode #8
How Jeff Park Turned a $200M Company Into $12.8 Billion
Jeff Park spent over a decade transforming SXC Health Solutions into Catamaran, a pharmacy benefits technology company that sold to UnitedHealthcare for $12.8 billion, a 65 times return on the original investment. He did it through 14 plus acquisitions, a relentless integration playbook, and one core belief: people are the only competitive advantage. In this episode of No Spotlight Needed, Jeff walks through how he earned the right to speak as a 25 year old sitting on ten boards, what the IPO taught him about investor storytelling, how to compete with your own customers and win, the three filters behind every M&A decision, why culture kills deals and how they stopped it, and what a year and a half in Portugal taught him about what actually matters. Let's connect: LinkedIn: / sheetal-mehta-prasad Our Website: https://www.nospotlightneeded.com Subscribe to the Channel: / @nospotlightneeded Timestamps: 1:27 - Introduction: Jeff Park and the SXC to Catamaran story 2:33 - Welcome and what Waltz Health does 3:09 - One drug, 2200 different prices: the problem Waltz is solving 4:27 - 14 million lives, $300 million saved: what it looks like in practice 5:25 - Starting in venture capital at Covington Capital in his 20s 6:31 - Sitting on ten boards as a 25 year old: what he actually contributed 8:17 - How to earn the right to speak when you are the youngest in the room 9:14 - The leverage equation: diligence before the check, none after 9:55 - Making the leap from investor to operator as CFO of SXC 10:51 - What he thought the job would look like versus what it actually was 11:09 - IPO lessons: who tells your story after the roadshow matters more than the bank name 12:03 - Why JPMorgan was the wrong choice for a $200M market cap company 12:20 - The Cory Tobin lesson: it is okay to say I do not know 13:45 - The post-it note Jeff carried on every earnings call for ten years 14:59 - At what point did they decide to become a PBM and compete with their own customers? 15:23 - The Formula One car in the lobby and the moment everything changed 16:44 - The first acquisition: NMC in 2008 for $143 million, all chips in 17:47 - Competing with clients: the pathway to control as the kill shot 19:52 - The M&A playbook: the three filters for every deal 20:52 - Why people retention is the real integration risk 21:13 - Tripling the EBITDA on NMC and turning skeptics into believers 21:39 - The integration playbook: one answer, one process, one platform 22:03 - Friday morning executive standups that ran for ten years 23:37 - How they knew the organization was ready for the next deal 24:54 - NMC to Catalyst: a $143M deal followed by a $4.4B deal 25:38 - The culture problem inside Catalyst: Sox fans and Cubs fans 26:57 - Changing the company name entirely and why it mattered 27:40 - Day one actions: the 90 day window that defines integration success 28:01 - Building a combined leadership team from both sides 29:39 - Selling to UnitedHealthcare for $12.8 billion 30:03 - What Jeff loved about United and why he still left after a year 31:02 - At 45 with kids aged 10 and 13, the decision to move to Portugal 34:02 - What you realize when you are never fully present anywhere 35:38 - A year and a half of reflection: how do I define myself when I am not working? 36:10 - Three things he decided he wanted from every chapter going forward 37:34 - The Welldyne opportunity: chairman and CEO, Carlyle backed, rinse and repeat 39:03 - Recruiting 40 former employees and building again from scratch 39:36 - If you are not buying you are dying: the PBM reality 41:01 - The FTC investigation and the real problem with PBM scale 42:00 - $600 billion in drug spend, $100 billion paid by patients, 100 million abandoned prescriptions 43:18 - What regulation actually creates: the conditions for disruption 44:16 - The Jeff and Mark dynamic: what makes a 20 year partnership work 45:32 - Joining Waltz Health: the right people, the right problem, the right moment
